Post-Marketing Pharmacovigilance And Medical Information Market Landscape 2025: Forecast Data and Growth Strategy Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Post-Marketing Pharmacovigilance And Medical Information Market Through 2025?
The size of the market for post-marketing pharmacovigilance and medical information has seen swift expansion in recent years. This market is expected to surge from a worth of $6.16 billion in 2024 to $6.90 billion in 2025, experiencing a compound annual growth rate (CAGR) of 11.9%. Factors contributing to the growth during the historic period include the increased incorporation of AI in pharmacovigilance activities, an escalating demand for contracted drug safety services, the increased intricacy of biopharmaceutical products, a heightened focus on patient-reported outcomes, and fostering collaboration between regulatory bodies and the industry.

What's the Projected Size of the Global Post-Marketing Pharmacovigilance And Medical Information Market by 2029?
In the coming years, the market size for post-marketing pharmacovigilance and medical information is projected to see a swift expansion, reaching a value of $10.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. This growth during the forecast period can be attributed to factors such as progress in drug safety analytic tools, growing usage of cloud-based pharmacovigilance solutions, an increasing number of novel therapeutic launches, an escalating focus on proactive risk management strategies, and burgeoning pharmacovigilance needs in emerging markets. The forecast period would also witness key trends including the advancement in automatic detection of adverse events, development of integrated pharmacovigilance platforms, innovation in real-time safety data monitoring, progress in patient engagement tools for safety reporting, and the creation of predictive analytics for the assessment of drug risks.

View the full report here:
https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Top Growth Drivers in the Post-Marketing Pharmacovigilance And Medical Information Industry: What's Accelerating the Market?
The escalating number of negative drug reactions is projected to fuel the expansion of the post-marketing pharmacovigilance and medical information market. Negative drug reactions pertain to damaging or unintended results that transpire when a drug is utilized at its recommended dosage for preventative, diagnostic, or therapeutic purposes. The frequency of these reactions increases as the elderly demographic increasingly requires medication for multiple chronic diseases, leading to the concurrent use of numerous drugs, which raises the possibility of detrimental drug interactions and unforeseen side effects. Post-marketing pharmacovigilance and medical information aid in managing negative drug reactions by identifying, monitoring, and disseminating information on possible side effects post-drug launch, ensuring its safety and efficacy. For example, Navikenz, a US-based IT services firm specializing in artificial intelligence, estimated in January 2023, that in the US, negative drug reactions are projected to result in 200,000 to 400,000 deaths annually, surpassing the combined deaths from stroke and diabetes, with an approximate 2.7 million cases each year resulting in over 100,000 hospital stays and more than 15,000 deaths. Thus, the escalating number of adverse drug reactions stimulates the growth of the post-marketing pharmacovigilance and medical information market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Are the Key Trends Driving Post-Marketing Pharmacovigilance And Medical Information Market Growth?
In the post-marketing pharmacovigilance and medical information market, principal companies are concentrating on developing more sophisticated solutions that utilize artificial intelligence. These AI-integrated solutions, such as pharmacovigilance workflows, aim to improve the precision of adverse event detection and provide real-time safety surveillance for improved patient health outcomes. In January 2024, for instance, UK cloud-based Software-as-a-Service (SaaS) company PubHive Ltd., launched a centralized Summary of Product Characteristics (SmPC) management platform. Its purpose is to serve life science companies and research organizations, amalgamating important drug safety data in a singular, easy-to-access database. The system automates procedure for monitoring literature and regulatory reporting, facilitates team cooperation, and simplifies compliance processes using advanced AI skills. These improvements allow pharmacovigilance teams to work more effectively and proactively, ensuring patient safety and regulatory compliance.

What Are the Main Segments in the Post-Marketing Pharmacovigilance And Medical Information Market?
The post-marketing pharmacovigilance and medical information market covered in this report is segmented

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining
2) By Product: Books, Online Media, Journals
3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:
1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting
2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems
3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting
4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring
5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Which Top Companies are Driving Growth in the Post-Marketing Pharmacovigilance And Medical Information Market?
Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., accenture* plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

Which Regions Will Dominate the Post-Marketing Pharmacovigilance And Medical Information Market Through 2029?
North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27393

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.